Asia Pacific Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, and Others) and End User (Diagnostic Laboratories & Reference Laboratories, Research Institutes, and Others)

TIPRE00024553 | Pages: 109 | Biotechnology | Sep 2021 | Type: Regional | Status: Published

Market Introduction

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

 

 

Market Overview and Dynamics

Countries such as India and China have large population suffering from chronic diseases. Thus, emerging markets in Asia-Pacific countries are creating significant opportunities for the business expansion of key histopathology services market players. Advancements in biotechnology have been encouraging the introduction of modern pathological systems that can be used in infectious disease testing, molecular oncology studies, and pharmacogenomics in emerging countries. Healthcare providers may target patients or consumers from various developing countries for studying diagnostic and histopathological tests. Further, the rising prevalence of various infectious diseases in these countries is likely to contribute to the growth of this market during the forecast period. Increasing research activities to develop effective treatments for chronic diseases are positively affecting the market growth. Researchers and therapists exploring therapies for these diseases conduct detailed histopathological analyses to understand the disease mechanisms, which assist in the designing of therapies for their management.

Countries in Asia Pacific are facing huge challenge due to continuous surge in COVID-19 cases. The disease outbreak has affected on diagnostic kits and drugs manufacturing, supply chains and distribution activities across the Asia Pacific region. This has hampered the performances of industries such as cancer diagnostics. Globally, histopathology and cytology workload reduced substantially which has hampered the market in the review period. Hence, a rapid increase in the number of infected patients in countries of Asia Pacific is likely to hamper the growth of histopathology services market.

 

Key Market Segments

The Asia Pacific histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. In 2021, the surgical specimen segment is likely to hold the largest share of the market, and it is further expected to register the highest CAGR during 2021–2028.

Based on end user, the Asia Pacific histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. The diagnostic laboratories and reference laboratories segment is likely to hold the largest share of the market in 2021, and it is anticipated to register the highest CAGR during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific histopathology services market are the Australian Cancer Research Foundation (ACRF), The Indian Council of Medical Research (ICMR) and National Health Service (NHS).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of Asia Pacific histopathology services market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Asia Pacific histopathology services market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific histopathology services market.

 

ASIA PACIFIC HISTOPATHOLOGY SERVICES MARKET SEGMENTATION

By Type of Examination

  • Surgical Specimen
  • Breast Biopsy
  • Lung Biopsy
  • Renal Biopsy
  • Gastrointestinal Biopsy
  • Pancreatic Biopsy
  • Skin Tissue Biopsy
  • Testicular Biopsy
  • Others

By End User

  • Diagnostic Laboratories & Reference Laboratories
  • Research Institutes
  • Others

By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Company Profiles

  • Sonic Healthcare Limited
  • TPL Path Labs
  • Targos
  • Cureline Global Translational CRO
  • CHARLES RIVER LABORATORIES, INC.

 

 

 

 

TABLE OF CONTENTS

1.           Introduction. 13

1.1         Scope of the Study. 13

1.2         The Insight Partners Research Report Guidance. 13

1.3         Market Segmentation. 15

1.3.1        Asia Pacific Histopathology Services Market – By Type of Examination. 17

1.3.2        Asia Pacific Histopathology Services Market – By End User 17

1.3.3        Asia Pacific Histopathology Services Market – By Country. 18

2.           Histopathology Services Market – Key Takeaways. 19

3.           Research Methodology. 22

3.1         Coverage. 24

3.2         Secondary Research. 24

3.3         Primary Research. 25

4.           Asia Pacific Histopathology Services Market – Market Landscape. 26

4.1         Overview.. 26

4.2         PEST Analysis. 27

4.2.1        Asia Pacific – PEST Analysis. 27

4.3         Expert Opinions. 28

5.           Histopathology Services Market – Key Market Dynamics. 29

5.1         Market Drivers. 29

5.1.1        Rising Demand for Biologics. 29

5.1.2        Increasing Prevalence of Chronic Diseases. 30

5.2         Market Restraints. 31

5.2.1        Limitations Associated with Histopathology and Immunohistochemistry. 31

5.3         Market Opportunities. 32

5.3.1        Potential Growth Opportunities in Emerging Economies. 32

5.4         Future Trends. 33

5.4.1        Strategic Alliances Among Market Players. 33

5.5         Impact Analysis. 34

6.           Histopathology Services Market – Asia Pacific Analysis. 35

6.1         Asia Pacific Histopathology Services Market Revenue Forecast and Analysis. 35

7.           Histopathology Services Market Analysis – By Type of Examination. 36

7.1         Overview.. 36

7.2         Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028) 36

7.3         Surgical Specimen. 37

7.3.1        Overview.. 37

7.3.2        Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 37

7.4         Breast Biopsy. 39

7.4.1        Overview.. 39

7.4.2        Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 39

7.5         Lung Biopsy. 41

7.5.1        Overview.. 41

7.5.2        Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 41

7.6         Renal Biopsy. 43

7.6.1        Overview.. 43

7.6.2        Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 43

7.7         Gastrointestinal Biopsy. 45

7.7.1        Overview.. 45

7.7.2        Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 45

7.8         Pancreatic Biopsy. 47

7.8.1        Overview.. 47

7.8.2        Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 47

7.9         Skin Tissue Biopsy. 49

7.9.1        Overview.. 49

7.9.2        Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 49

7.10      Testicular Biopsy. 51

7.10.1     Overview.. 51

7.10.2     Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 51

7.11      Others. 53

7.11.1     Overview.. 53

7.11.2     Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 53

8.           Histopathology Services Market Analysis – By End User 55

8.1         Overview.. 55

8.2         Histopathology Services Market Share, by End User, 2021 and 2028, (%) 55

8.3         Diagnostic Laboratories and Reference Laboratories. 56

8.3.1        Overview.. 56

8.3.2        Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 56

8.4         Research Institutes. 58

8.4.1        Overview.. 58

8.4.2        Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 58

8.5         Others. 60

8.5.1        Overview.. 60

8.5.2        Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 60

9.           Histopathology Services Market – Asia Pacific Analysis. 62

9.1         Asia Pacific: Histopathology Services Market 62

9.1.1        Overview.. 62

9.1.2        Asia Pacific: Histopathology Services Market, by Country, 2021 & 2028 (%) 64

9.1.3        China: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 65

9.1.3.1          China: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 66

9.1.3.2          China: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 67

9.1.3.3          China: Histopathology Services Market, by End User, 2019-2028 (USD Million) 68

9.1.4        Japan: Histopathology Services Market - Revenue and Forecast to 2028 (USD Million) 69

9.1.4.1          Japan: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 69

9.1.4.2          Japan: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 71

9.1.4.3          Japan: Histopathology Services Market, by End User, 2019-2028 (USD Million) 72

9.1.5        India: Histopathology Services Market - Revenue and Forecast to 2028 (USD Million) 73

9.1.5.1          India: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 73

9.1.5.2          India: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 75

9.1.5.3          India: Histopathology Services Market, by End User, 2019-2028 (USD Million) 76

9.1.6        South Korea: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 77

9.1.6.1          South Korea: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 77

9.1.6.2          South Korea: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 79

9.1.6.3          South Korea: Histopathology Services Market, by End User, 2019-2028 (USD Million) 80

9.1.7        Australia: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 81

9.1.7.1          Australia: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 82

9.1.7.2          Australia: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 83

9.1.7.3          Australia: Histopathology Services Market, by End User, 2019-2028 (USD Million) 84

9.1.8        Rest of Asia Pacific: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 85

9.1.8.1          Rest of Asia Pacific: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million) 85

9.1.8.2          Rest of Asia Pacific: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million) 86

9.1.8.3          Rest of Asia Pacific: Histopathology Services Market, by End User, 2019-2028 (USD Million) 87

10.        Impact of COVID-19 Pandemic on Asia Pacific Histopathology Services Market 88

10.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic. 88

11.        Industry Landscape. 90

11.1      Overview.. 90

11.2      Developments by Key Market Players. 90

11.2.1     Overview.. 90

12.        Company Profiles. 92

12.1      Sonic Healthcare Limited. 92

12.1.1     Key Facts. 92

12.1.2     Business Description. 92

12.1.3     Products and Services. 93

12.1.4     Financial Overview.. 93

12.1.5     SWOT Analysis. 95

12.1.6     Key Developments. 95

12.2      TPL Path Labs. 96

12.2.1     Key Facts. 96

12.2.2     Business Description. 96

12.2.3     Products and Services. 96

12.2.4     Financial Overview.. 96

12.2.5     SWOT Analysis. 97

12.2.6     Key Developments. 97

12.3      Cureline Global Translational CRO.. 98

12.3.1     Key Facts. 98

12.3.2     Business Description. 98

12.3.3     Products and Services. 99

12.3.4     Financial Overview.. 99

12.3.5     SWOT Analysis. 100

12.3.6     Key Developments. 100

12.4      Targos. 101

12.4.1     Key Facts. 101

12.4.2     Business Description. 101

12.4.3     Products and Services. 101

12.4.4     Financial Overview.. 102

12.4.5     SWOT Analysis. 102

12.4.6     Key Developments. 102

12.5      CHARLES RIVER LABORATORIES, INC. 103

12.5.1     Key Facts. 103

12.5.2     Business Description. 103

12.5.3     Products and Services. 104

12.5.4     Financial Overview.. 105

12.5.5     SWOT Analysis. 107

12.5.6     Key Developments. 107

13.        Appendix. 108

13.1      About The Insight Partners. 108

13.2      Glossary of Terms. 109

 


LIST OF TABLES

Table 1.             China Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 67

Table 2.             China Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 68

Table 3.             Japan Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 71

Table 4.             Japan Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 72

Table 5.             India Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 75

Table 6.             India Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 76

Table 7.             South Korea Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 79

Table 8.             South Korea Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 80

Table 9.             Incidence, Mortality and Prevalence by cancer site, Australia, 2018. 81

Table 10.          Australia Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 83

Table 11.          Australia Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 84

Table 12.          Rest of Asia Pacific Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million) 86

Table 13.          Rest of Asia Pacific Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million) 87

Table 14.          Developments Done by Key Players. 91

Table 15.          Glossary of Terms, Histopathology Services Market 109

 


LIST OF FIGURES

Figure 1.           Histopathology Services Market Segmentation. 15

Figure 2.           Histopathology Services Market Segmentation, By Country. 16

Figure 3.           Histopathology Services Market Overview.. 19

Figure 4.           Surgical Specimen Segment Held Largest Share of Histopathology Services Market 20

Figure 5.           Asia Pacific Histopathology Services Market – Leading Country Markets (US$ Million) 21

Figure 6.           Asia Pacific PEST Analysis. 27

Figure 7.           Histopathology Services Market Impact Analysis of Drivers and Restraints. 34

Figure 8.           Asia Pacific Histopathology Services Market – Revenue Forecast and Analysis – 2020- 2028. 35

Figure 9.           Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028) 36

Figure 10.        Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 38

Figure 11.        Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 40

Figure 12.        Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 42

Figure 13.        Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 44

Figure 14.        Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 46

Figure 15.        Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 48

Figure 16.        Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 50

Figure 17.        Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 52

Figure 18.        Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 54

Figure 19.        Histopathology Services Market Share, by End User, 2021 and 2028 (%) 55

Figure 20.        Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 57

Figure 21.        Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 59

Figure 22.        Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million) 61

Figure 23.        Asia Pacific: Histopathology Services Market, by Key Country – Revenue (2021) (USD Millions) 63

Figure 24.        Asia Pacific: Histopathology Services Market, by Country, 2021 & 2028 (%) 64

Figure 25.        China Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 66

Figure 26.        Japan Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 70

Figure 27.        India Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 74

Figure 28.        South Korea Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 78

Figure 29.        Australia Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 82

Figure 30.        Rest of Asia Pacific Histopathology Services Market Revenue and Forecast to 2028 (USD Million) 85

Figure 31.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets. 89

 

  • Sonic Healthcare Limited
  • TPL Path Labs
  • Targos
  • Cureline Global Translational CRO
  • CHARLES RIVER LABORATORIES, INC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific histopathology services market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific histopathology services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000